Company Profile

Biospeech Inc
Profile last edited on: 11/20/19      CAGE: 468A8      UEI: ZNXDMFF4L5J5

Business Identifier: Biomedical applications speech technology
Year Founded
2004
First Award
2006
Latest Award
2019
Program Status
Active
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

4640 SW Macadam Avenue UNit 250
Portland, OR 97239
   (503) 341-1192
   vansanten@biospeech.com
   www.biospeech.com
Location: Single
Congr. District: 05
County: Clackamas

Public Profile

Coming out of, and retaining ties to, the Center for Spoken Language Understanding, one of the world’s premier academic speech technology centers at the acclaimed Oregon Health & Science University medical school. BioSpeech, Inc. is an R&D company with principals having in-depth expertise in speech technology, speech language pathology, audiology, and neuropsychology. The firm organizes around creating speech technology based software solutions for people with language, speech, hearing, breathing problems. Sophisticated, easy-to-use, low-cost, research-based solutions have been developed to help people better to communicate.

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
1-4
Revenue Range
Less than .5M
VC funded?
No
Public/Private
Privately Held
Stock Info
----
IP Holdings
N/A

Awards Distribution by Agency

Most Recent SBIR Projects

Year Phase Agency Total Amount
2019 1 NIH $225,000
Project Title: Audiobooks for Hearing Loss
2018 2 NIH $1,634,256
Project Title: Prosody Assessment Toolbox
2015 2 NIH $617,118
Project Title: System for Automatic Classification of Rodent Vocalizations
2013 1 NIH $234,295
Project Title: Screening For Sleep Disordered Breathing With Minimally Obtrusive Sensors
2012 2 NIH $1,075,638
Project Title: Computer Assisted Disfluency Counts for Stuttered Speech

Key People / Management

  Jan Vansanten -- President and CEO

  Pamela A Connors -- Product Design and Evaluation Director

  Peter A Heeman

  Alexander Kain -- CTO

  Esther Klabbers

  Garet Lahvis

  Kirsty Lindaas-Hamilton

  Brian Robert Snider

  Richard W Sproat

Company News

There are no news available.